Menarini Invests 150 Million Euros in a New Pharmaceutical Plant in Italy

Menarini chooses Italy for its new €150 million manufacturing site.

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

Menarini Group and Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, (Nasdaq: STML) today announced a definitive agreement under which Menarini Group will acquire Stemline in a transaction valued up to $677 million.

Menarini: Elcin Barker Ergun Group CEO

The Board of Directors has appointed Mrs. Elcin Barker Ergun  as CEO of Menarini Group.

Menarini's evening with the stars of Fair Play

The 23rd Menarini International Fair Play Awards will take place in Florence. An evening dedicated...

Scroll Top